Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX4 vs Doxorubicin in Advanced Hepatocellular Carcinoma
NCT00471965Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Mar 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 3 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by Sanofi. Started Mar 2007; status: completed.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00471965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471965.